ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Overview Fund Activity
Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

21 hedge funds and large institutions have $26.3M invested in Zynerba Pharmaceuticals, Inc in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-5
Holders Change %
-19.23%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
–
Closed
12
Calls
$191K
Puts
$315K
Net Calls
-$124K
Net Calls Change
-$124K

Top Buyers

1
BCM
1
Bridgeway Capital Management
Texas
$757K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$605K
3
Northern Trust
3
Northern Trust
Illinois
$297K
4
PA
4
Perceptive Advisors
New York
$11.3M
5
Citadel Advisors
5
Citadel Advisors
Florida
$218K

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
NC
2
Nexthera Capital
New York
$0
3
AGM
3
Alpine Global Management
New York
$0
4
CS
4
Credit Suisse
Switzerland
$0
5
PP
5
Paloma Partners
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PP
26
Paloma Partners
Connecticut
– -$87K -12,750 Closed
Bank of New York Mellon
27
Bank of New York Mellon
New York
– -$69K -10,129 Closed
Deutsche Bank
28
Deutsche Bank
Germany
– -$27K -3,943 Closed
PCM
29
Prelude Capital Management
New York
– -$14K -2,000 Closed
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
– -$12K -1,800 Closed
Bank of America
31
Bank of America
North Carolina
– -$7K -1,018 Closed
Barclays
32
Barclays
United Kingdom
– -$3K -371 Closed
TRCT
33
Tower Research Capital (TRC)
New York
– -$2K -224 Closed
1
2